Hypnic Headache with Dopaminergic Neuron Dysfunction: New Insight from a Rare Case

Pain Med. 2019 Aug 1;20(8):1639-1642. doi: 10.1093/pm/pnz044.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benserazide / therapeutic use
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Cocaine / analogs & derivatives
  • Dopamine Agents / therapeutic use
  • Dopamine Uptake Inhibitors
  • Dopaminergic Neurons / metabolism*
  • Drug Combinations
  • Fluorodeoxyglucose F18
  • Headache Disorders, Primary / diagnostic imaging
  • Headache Disorders, Primary / drug therapy
  • Headache Disorders, Primary / metabolism*
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Putamen / diagnostic imaging
  • Putamen / metabolism*
  • Radiopharmaceuticals

Substances

  • Dopamine Agents
  • Dopamine Uptake Inhibitors
  • Drug Combinations
  • Radiopharmaceuticals
  • benserazide, levodopa drug combination
  • Fluorodeoxyglucose F18
  • Levodopa
  • (1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester
  • Benserazide
  • Cocaine